{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T01:40:36Z","timestamp":1787794836401,"version":"build-2784847793"},"reference-count":52,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2015,7,1]],"date-time":"2015-07-01T00:00:00Z","timestamp":1435708800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,7,1]],"date-time":"2015-07-01T00:00:00Z","timestamp":1435708800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["dmd.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Metabolism and Disposition"],"published-print":{"date-parts":[[2015,7]]},"DOI":"10.1124\/dmd.115.064352","type":"journal-article","created":{"date-parts":[[2015,4,21]],"date-time":"2015-04-21T01:42:30Z","timestamp":1429580550000},"page":"994-1001","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":62,"title":["Differences in Methadone Metabolism by CYP2B6 Variants"],"prefix":"10.1016","volume":"43","author":[{"given":"Sarah","family":"Gadel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Friedel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evan D.","family":"Kharasch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/dmd.115.064352_bib1","doi-asserted-by":"crossref","first-page":"22080","DOI":"10.1074\/jbc.M112.448225","article-title":"A model of the membrane-bound cytochrome b5-cytochrome P450 complex from NMR and mutagenesis data","volume":"288","author":"Ahuja","year":"2013","journal-title":"J Biol Chem"},{"key":"10.1124\/dmd.115.064352_bib2","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1124\/dmd.111.039586","article-title":"Q172H replacement overcomes effects on the metabolism of cyclophosphamide and efavirenz caused by CYP2B6 variant with Arg262","volume":"39","author":"Ariyoshi","year":"2011","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.115.064352_bib3","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1586\/ecp.13.18","article-title":"A review of pharmacological interactions between HIV or hepatitis C virus medications and opioid agonist therapy: implications and management for clinical practice","volume":"6","author":"Bruce","year":"2013","journal-title":"Expert Rev Clin Pharmacol"},{"key":"10.1124\/dmd.115.064352_bib4","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/j.1742-7843.2010.00628.x","article-title":"Stereo-selective metabolism of methadone by human liver microsomes and cDNA-expressed cytochrome P450s: a reconciliation","volume":"108","author":"Chang","year":"2011","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"10.1124\/dmd.115.064352_bib5","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.clpt.2005.08.011","article-title":"Methadone enantiomer plasma levels, CYP2B6, CYP2C19, and CYP2C9 genotypes, and response to treatment","volume":"78","author":"Crettol","year":"2005","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/dmd.115.064352_bib6","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.clpt.2006.09.012","article-title":"ABCB1 and cytochrome P450 genotypes and phenotypes: influence on methadone plasma levels and response to treatment","volume":"80","author":"Crettol","year":"2006","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/dmd.115.064352_bib7","doi-asserted-by":"crossref","first-page":"547","DOI":"10.2217\/14622416.8.6.547","article-title":"Impact of CYP2B6 polymorphism on hepatic efavirenz metabolism in vitro","volume":"8","author":"Desta","year":"2007","journal-title":"Pharmacogenomics"},{"key":"10.1124\/dmd.115.064352_bib8","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1021\/bi00625a014","article-title":"NADPH-cytochrome P-450 reductase from rat liver: purification by affinity chromatography and characterization","volume":"16","author":"Dignam","year":"1977","journal-title":"Biochemistry"},{"key":"10.1124\/dmd.115.064352_bib9","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1038\/sj.clpt.6100120","article-title":"Stereoselective block of hERG channel by (S)-methadone and QT interval prolongation in CYP2B6 slow metabolizers","volume":"81","author":"Eap","year":"2007","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/dmd.115.064352_bib10","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.phrs.2004.05.002","article-title":"Methadone\u2014metabolism, pharmacokinetics and interactions","volume":"50","author":"Ferrari","year":"2004","journal-title":"Pharmacol Res"},{"key":"10.1124\/dmd.115.064352_bib11","doi-asserted-by":"crossref","first-page":"31385","DOI":"10.1074\/jbc.M803496200","article-title":"Defining the in vivo role for cytochrome b5 in cytochrome P450 function through the conditional hepatic deletion of microsomal cytochrome b5.","volume":"283","author":"Finn","year":"2008","journal-title":"J Biol Chem"},{"key":"10.1124\/dmd.115.064352_bib12","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1124\/dmd.112.050625","article-title":"Methadone N-demethylation by the common CYP2B6 allelic variant CYP2B6.6","volume":"41","author":"Gadel","year":"2013","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.115.064352_bib13","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1002\/chir.10303","article-title":"Stereoselective metabolism of methadone N-demethylation by cytochrome P4502B6 and 2C19","volume":"16","author":"Gerber","year":"2004","journal-title":"Chirality"},{"key":"10.1124\/dmd.115.064352_bib14","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1002\/cpdd.137","article-title":"Drug interactions with methadone: Time to revise the product label","volume":"3","author":"Greenblatt","year":"2014","journal-title":"Clin Pharmacol Drug Dev"},{"key":"10.1124\/dmd.115.064352_bib15","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/0003-9861(71)90186-X","article-title":"Evidence for the participation of cytochrome b 5 in hepatic microsomal mixed-function oxidation reactions","volume":"143","author":"Hildebrandt","year":"1971","journal-title":"Arch Biochem Biophys"},{"key":"10.1124\/dmd.115.064352_bib16","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1124\/jpet.107.133306","article-title":"Aberrant splicing caused by single nucleotide polymorphism c.516G>T [Q172H], a marker of CYP2B6*6, is responsible for decreased expression and activity of CYP2B6 in liver","volume":"325","author":"Hofmann","year":"2008","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/dmd.115.064352_bib17","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1124\/dmd.111.040352","article-title":"Functional characterization of CYP2B6 allelic variants in demethylation of antimalarial artemether","volume":"39","author":"Honda","year":"2011","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.115.064352_bib18","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.2217\/pgs.11.96","article-title":"Impact of genetic polymorphisms in ABCB1, CYP2B6, OPRM1, ANKK1 and DRD2 genes on methadone therapy in Han Chinese patients","volume":"12","author":"Hung","year":"2011","journal-title":"Pharmacogenomics"},{"key":"10.1124\/dmd.115.064352_bib19","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.abb.2010.10.023","article-title":"The interaction of microsomal cytochrome P450 2B4 with its redox partners, cytochrome P450 reductase and cytochrome b(5)","volume":"507","author":"Im","year":"2011","journal-title":"Arch Biochem Biophys"},{"key":"10.1124\/dmd.115.064352_bib20","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.1124\/dmd.113.053991","article-title":"Cytochrome P4503A does not mediate the interaction between methadone and ritonavir-lopinavir","volume":"41","author":"Kharasch","year":"2013","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.115.064352_bib21","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1002\/jcph.1","article-title":"Role of cytochrome P4502B6 in methadone metabolism and clearance","volume":"53","author":"Kharasch","year":"2013","journal-title":"J Clin Pharmacol"},{"key":"10.1124\/dmd.115.064352_bib22","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.clpt.2004.05.003","article-title":"Role of hepatic and intestinal cytochrome P450 3A and 2B6 in the metabolism, disposition, and miotic effects of methadone","volume":"76","author":"Kharasch","year":"2004","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/dmd.115.064352_bib23","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1038\/clpt.2008.104","article-title":"Mechanism of ritonavir changes in methadone pharmacokinetics and pharmacodynamics: I. Evidence against CYP3A mediation of methadone clearance","volume":"84","author":"Kharasch","year":"2008","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/dmd.115.064352_bib24","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1128\/AAC.01600-07","article-title":"Rapid clinical induction of hepatic cytochrome P4502B6 activity by ritonavir","volume":"52","author":"Kharasch","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1124\/dmd.115.064352_bib25","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1097\/ALN.0b013e3182423478","article-title":"Lack of indinavir effects on methadone disposition despite inhibition of hepatic and intestinal cytochrome P4503A (CYP3A)","volume":"116","author":"Kharasch","year":"2012","journal-title":"Anesthesiology"},{"key":"10.1124\/dmd.115.064352_bib26","first-page":"S53","article-title":"Methadone enantiomers metabolism and clearance are impaired in individuals with CYP2B6*6 genotype","volume":"95","author":"Kharasch","year":"2014","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/dmd.115.064352_bib27","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1097\/00008571-200107000-00004","article-title":"Extensive genetic polymorphism in the human CYP2B6 gene with impact on expression and function in human liver","volume":"11","author":"Lang","year":"2001","journal-title":"Pharmacogenetics"},{"key":"10.1124\/dmd.115.064352_bib28","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1006\/abbi.1995.1278","article-title":"CYP3A4 expressed by insect cells infected with a recombinant baculovirus containing both CYP3A4 and human NADPH-cytochrome P450 reductase is catalytically similar to human liver microsomal CYP3A4","volume":"319","author":"Lee","year":"1995","journal-title":"Arch Biochem Biophys"},{"key":"10.1124\/dmd.115.064352_bib29","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1111\/j.1369-1600.2011.00349.x","article-title":"CYP2B6 SNPs are associated with methadone dose required for effective treatment of opioid addiction","volume":"18","author":"Levran","year":"2013","journal-title":"Addict Biol"},{"key":"10.1124\/dmd.115.064352_bib30","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1124\/dmd.113.051631","article-title":"The CYP2B6*6 allele significantly alters the N-demethylation of ketamine enantiomers in vitro","volume":"41","author":"Li","year":"2013","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.115.064352_bib31","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/0003-2697(76)90114-7","article-title":"Quantitative determination of cytochrome P-450 in rat liver homogenate","volume":"75","author":"Matsubara","year":"1976","journal-title":"Anal Biochem"},{"key":"10.1124\/dmd.115.064352_bib32","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1124\/mol.110.064246","article-title":"Deletion of microsomal cytochrome b5 profoundly affects hepatic and extrahepatic drug metabolism","volume":"78","author":"McLaughlin","year":"2010","journal-title":"Mol Pharmacol"},{"key":"10.1124\/dmd.115.064352_bib33","doi-asserted-by":"crossref","first-page":"730","DOI":"10.2174\/138920009789895534","article-title":"Substrate specificity, regulation, and polymorphism of human cytochrome P450 2B6","volume":"10","author":"Mo","year":"2009","journal-title":"Curr Drug Metab"},{"key":"10.1124\/dmd.115.064352_bib34","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1002\/jps.10091","volume":"91","author":"Nakajima","year":"2002","journal-title":"J Pharm Sci"},{"key":"10.1124\/dmd.115.064352_bib35","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1097\/FPC.0b013e32835c2ddf","article-title":"Functional characterization of eight human CYP1A2 variants: the role of cytochrome b5.","volume":"23","author":"Palma","year":"2013","journal-title":"Pharmacogenet Genomics"},{"key":"10.1124\/dmd.115.064352_bib36","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1038\/nbt0897-784","article-title":"Drug metabolism by Escherichia coli expressing human cytochromes P450","volume":"15","author":"Parikh","year":"1997","journal-title":"Nat Biotechnol"},{"key":"10.1124\/dmd.115.064352_bib37","first-page":"493","article-title":"Vital signs: risk for overdose from methadone used for pain relief - United States, 1999-2010","volume":"61","author":"Paulozzi","year":"2012","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1124\/dmd.115.064352_bib38","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1124\/dmd.111.039347","article-title":"Potential contribution of cytochrome P450 2B6 to hepatic 4-hydroxycyclophosphamide formation in vitro and in vivo","volume":"40","author":"Raccor","year":"2012","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.115.064352_bib39","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1002\/humu.22295","article-title":"Novel CYP2B6 enzyme variants in a Rwandese population: functional characterization and assessment of in silico prediction tools","volume":"34","author":"Radloff","year":"2013","journal-title":"Hum Mutat"},{"key":"10.1124\/dmd.115.064352_bib40","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0163-7258(02)00327-3","article-title":"The many roles of cytochrome b5","volume":"97","author":"Schenkman","year":"2003","journal-title":"Pharmacol Ther"},{"key":"10.1124\/dmd.115.064352_bib41","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1124\/jpet.106.117580","article-title":"Enantiomeric metabolic interactions and stereoselective human methadone metabolism","volume":"321","author":"Totah","year":"2007","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/dmd.115.064352_bib42","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1097\/ALN.0b013e3181642938","article-title":"Role of CYP2B6 in stereoselective human methadone metabolism","volume":"108","author":"Totah","year":"2008","journal-title":"Anesthesiology"},{"key":"10.1124\/dmd.115.064352_bib43","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1515\/dmdi-2012-0027","article-title":"Cytochrome P450 2B6: function, genetics, and clinical relevance","volume":"27","author":"Turpeinen","year":"2012","journal-title":"Drug Metabol Drug Interact"},{"key":"10.1124\/dmd.115.064352_bib44","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.1128\/AAC.02262-12","article-title":"Pharmacokinetic interaction between telaprevir and methadone","volume":"57","author":"van Heeswijk","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1124\/dmd.115.064352_bib45","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.drugalcdep.2012.05.009","article-title":"Effect of lersivirine co-administration on pharmacokinetics of methadone in healthy volunteers","volume":"126","author":"Vourvahis","year":"2012","journal-title":"Drug Alcohol Depend"},{"key":"10.1124\/dmd.115.064352_bib46","doi-asserted-by":"crossref","first-page":"598","DOI":"10.2174\/138920008785821710","article-title":"CYP2B6: new insights into a historically overlooked cytochrome P450 isozyme","volume":"9","author":"Wang","year":"2008","journal-title":"Curr Drug Metab"},{"key":"10.1124\/dmd.115.064352_bib47","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1097\/JCP.0b013e318222b5dd","article-title":"CYP2B6 polymorphisms influence the plasma concentration and clearance of the methadone S-enantiomer","volume":"31","author":"Wang","year":"2011","journal-title":"J Clin Psychopharmacol"},{"key":"10.1124\/dmd.115.064352_bib48","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1097\/FPC.0b013e32833bba0e","article-title":"Functional characterization of 26 CYP2B6 allelic variants (CYP2B6.2-CYP2B6.28, except CYP2B6.22)","volume":"20","author":"Watanabe","year":"2010","journal-title":"Pharmacogenet Genomics"},{"key":"10.1124\/dmd.115.064352_bib49","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/sj.tpj.6500157","article-title":"Role of polymorphic human CYP2B6 in cyclophosphamide bioactivation","volume":"3","author":"Xie","year":"2003","journal-title":"Pharmacogenomics J"},{"key":"10.1124\/dmd.115.064352_bib50","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1124\/dmd.111.042416","article-title":"Effects of the CYP2B6*6 allele on catalytic properties and inhibition of CYP2B6 in vitro: implication for the mechanism of reduced efavirenz metabolism and other CYP2B6 substrates in vivo","volume":"40","author":"Xu","year":"2012","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.115.064352_bib51","doi-asserted-by":"crossref","first-page":"24","DOI":"10.3389\/fgene.2013.00024","article-title":"Pharmacogenetics of cytochrome P450 2B6 (CYP2B6): advances on polymorphisms, mechanisms, and clinical relevance","volume":"4","author":"Zanger","year":"2013","journal-title":"Front Genet"},{"key":"10.1124\/dmd.115.064352_bib52","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1124\/jpet.111.183111","article-title":"Polymorphic variants of cytochrome P450 2B6 (CYP2B6.4-CYP2B6.9) exhibit altered rates of metabolism for bupropion and efavirenz: a charge-reversal mutation in the K139E variant (CYP2B6.8) impairs formation of a functional cytochrome p450-reductase complex","volume":"338","author":"Zhang","year":"2011","journal-title":"J Pharmacol Exp Ther"}],"container-title":["Drug Metabolism and Disposition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624113293?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624113293?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/dmd.115.064352","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T19:31:43Z","timestamp":1739907103000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090955624113293"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7]]},"references-count":52,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2015,7]]}},"alternative-id":["S0090955624113293"],"URL":"https:\/\/doi.org\/10.1124\/dmd.115.064352","relation":{},"ISSN":["0090-9556"],"issn-type":[{"value":"0090-9556","type":"print"}],"subject":[],"published":{"date-parts":[[2015,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Differences in Methadone Metabolism by CYP2B6 Variants","name":"articletitle","label":"Article Title"},{"value":"Drug Metabolism and Disposition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/dmd.115.064352","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2015 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}